Work

Subgroup analysis of elderly patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.11575

Authors: Eugenie Younger, Zsuzsanna Papai, Brian Andrew Van Tine, Steven Attia, Karla V. Ballman, Yao Lu, Denise K. Reinke, Patrick Schoffski, William D. Tap, Robin Lewis Jones

Institutions: Royal Marsden Hospital, Washington University in St. Louis, Mayo Clinic in Florida, Weill Cornell Medicine, NewYork–Presbyterian Hospital, Sarcoma Alliance for Research through Collaboration, KU Leuven, Memorial Sloan Kettering Cancer Center, Institute of Cancer Research

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4245923462

Cites:

Cited by:

Related to: 10